Diabetes Discourse
As the number of Americans living with diabetes continues to rise, staying up to date on the latest diabetes research is more essential than ever to help patients achieve glucose control. With Diabetes Discourse, you’ll hear from diabetes and endocrinology experts on emerging research, diagnostic and treatment strategies, and various elements that impact a patient’s disease course, including risk factors, vitamin and mineral supplementation, physical activity, and kidney disease.
Because when it comes to diabetes, glucose control is just the beginning.
196-210 of 219
The Importance of Immunizations for Diabetic Patients
Diabetes DiscourseThe Importance of Immunizations for Diabetic Patients
Sarah Lorentz, PharmD
Candis Morello, PharmD, CDE
Drug Delivery Systems in the Management of Diabetes
Diabetes DiscourseDrug Delivery Systems in the Management of Diabetes
Candis Morello, PharmD, CDE
Brookie Best, PharmD
New AACE Guidelines for Treating Type 2 Diabetes
Diabetes DiscourseNew AACE Guidelines for Treating Type 2 Diabetes
Daniel Einhorn, MD
Steven Edelman, MD
David Ward, MD
Steven Edelman, MD
NICE-SUGAR: Blood Glucose Levels in the ICU
Diabetes DiscourseNICE-SUGAR: Blood Glucose Levels in the ICU
Irl Hirsch, MD, MACP
Steven Edelman, MD
Thomas Moore, MD
Steven Edelman, MD
- advertisement
Weighing Therapeutic Diets for Type 2 Diabetics
Diabetes DiscourseWeighing Therapeutic Diets for Type 2 Diabetics
Steven Edelman, MD
Lorena Drago, MS, RD, CDN, CDE
Sodium-Glucose Transporters: A New Class of Diabetes Medications
Diabetes DiscourseSodium-Glucose Transporters: A New Class of Diabetes Medications
Steven Edelman, MD
Vivian Fonseca, MD, FRCP
A New Paradigm for the Treatment of Type 2 Diabetes
Diabetes DiscourseA New Paradigm for the Treatment of Type 2 Diabetes
Ralph A. DeFronzo, MD
Steven Edelman, MD
Do Incretins Play An Important Role In the Cardiovascular System?
Diabetes DiscourseDo Incretins Play An Important Role In the Cardiovascular System?
John Buse, MD, PhD
Steven Edelman, MD
The Diabetes Infrastructure: Regulation & Reimbursement
Diabetes DiscourseThe Diabetes Infrastructure: Regulation & Reimbursement
Kelly Close, MBA
Steven Edelman, MD
New Developments in Incretins and SGLT Inhibitors
Diabetes DiscourseNew Developments in Incretins and SGLT Inhibitors
Robert Henry, MD
Steven Edelman, MD
- advertisement
Daniel Blanchard, MD
Steven Edelman, MD
Patrick J. Boyle, MD
Steven Edelman, MD
New Treatments for Peripheral Diabetic Neuropathy
Diabetes DiscourseNew Treatments for Peripheral Diabetic Neuropathy
Ingrid Kruse, DPM
Steven Edelman, MD